The well-established digital immunohistochemistry-based method Immunoscore assessing the host anti-tumoral response quantifies two (CD3 and CD8) lymphocyte populations at both the invasive margin (IM) and at the core of the tumor (CT) [25,26]. Here, CD8A is linked to neoplasm.